Burning Rock Biotech (BNR) Other financing activities (2020 - 2025)
Historic Other financing activities for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $703.3 million.
- Burning Rock Biotech's Other financing activities fell 122.73% to $703.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $703.3 million, marking a year-over-year decrease of 122.73%. This contributed to the annual value of $685.3 million for FY2024, which is 33.54% up from last year.
- Latest data reveals that Burning Rock Biotech reported Other financing activities of $703.3 million as of Q3 2025, which was down 122.73% from $698.9 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Other financing activities registered a high of $712.1 million during Q3 2024, and its lowest value of $624.3 million during Q1 2021.
- In the last 5 years, Burning Rock Biotech's Other financing activities had a median value of $678.7 million in 2023 and averaged $671.9 million.
- Per our database at Business Quant, Burning Rock Biotech's Other financing activities surged by 2020.55% in 2021 and then plummeted by 344.26% in 2022.
- Quarter analysis of 5 years shows Burning Rock Biotech's Other financing activities stood at $671.8 million in 2021, then dropped by 1.09% to $664.4 million in 2022, then increased by 2.8% to $683.0 million in 2023, then grew by 0.34% to $685.3 million in 2024, then rose by 2.63% to $703.3 million in 2025.
- Its Other financing activities was $703.3 million in Q3 2025, compared to $698.9 million in Q2 2025 and $689.8 million in Q1 2025.